{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:42:34Z","timestamp":1707525754328},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.7759\/cureus.53323","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T19:08:25Z","timestamp":1706728105000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Epstein-Barr Virus-Negative Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient With Untreated Chronic Hepatitis C"],"prefix":"10.7759","author":[{"given":"Edgar","family":"Asiimwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami J","year":"2003","unstructured":"Adami J, G\u00e4bel H, Lindel\u00f6f B, et al.. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003, 89:1221-7. 10.1038\/sj.bjc.6601219","journal-title":"Br J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-113667","article-title":"Clinical characteristics and outcomes of an analysis of a single institution experience of the 2017 World Health Organization (WHO) classification of post-transplant lymphoproliferative disorders (PTLD)","volume":"132","author":"Habermann TM","year":"2018","unstructured":"Habermann TM, Fama A, Ristow KM, et al.. Clinical characteristics and outcomes of an analysis of a single institution experience of the 2017 World Health Organization (WHO) classification of post-transplant lymphoproliferative disorders (PTLD). Blood. 2018, 132:456.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14748\/vmf.v12i1.9034","article-title":"Lymph nodes of the head and neck: in normal and pathological conditions","volume":"12","author":"Nikolaev N","year":"2023","unstructured":"Nikolaev N, Yankov Y. Lymph nodes of the head and neck: in normal and pathological conditions. Varna Med Forum. 2023, 12:74. 10.14748\/vmf.v12i1.9034","journal-title":"Varna Med Forum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker RC","year":"1995","unstructured":"Walker RC, Marshall WF, Strickler JG, et al.. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995, 20:1346-53. 10.1093\/clinids\/20.5.1346","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2594.bloodjournal8762594","article-title":"The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation","volume":"87","author":"Lucas KG","year":"1996","unstructured":"Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 1996, 87:2594-603. 10.1182\/blood.V87.6.2594.bloodjournal8762594","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz G","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993, 342:1514-6. 10.1016\/s0140-6736(05)80084-4","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401390","article-title":"Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8","volume":"13","author":"Dotti G","year":"1999","unstructured":"Dotti G, Fiocchi R, Motta T, et al.. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999, 13:664-70. 10.1038\/sj.leu.2401390","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02740.x","article-title":"Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma","volume":"113","author":"Kapelushnik J","year":"2001","unstructured":"Kapelushnik J, Ariad S, Benharroch D, Landau D, Moser A, Delsol G, Brousset P. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001, 113:425-8. 10.1046\/j.1365-2141.2001.02740.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2033539","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"384","author":"Cacoub P","year":"2021","unstructured":"Cacoub P, Saadoun D. Extrahepatic manifestations of chronic HCV infection. N Engl J Med. 2021, 384:1038-52. 10.1056\/NEJMra2033539","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose S","year":"2008","unstructured":"de Sanjose S, Benavente Y, Vajdic CM, et al.. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008, 6:451-8. 10.1016\/j.cgh.2008.02.011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-101956","article-title":"Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients","volume":"110","author":"Morton LM","year":"2007","unstructured":"Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, Engels EA. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood. 2007, 110:4599-605. 10.1182\/blood-2007-07-101956","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone M","year":"1995","unstructured":"Magnone M, Holley JL, Shapiro R, et al.. Interferon-alpha-induced acute renal allograft rejection. Transplantation. 1995, 59:1068-70. 10.1097\/00007890-199504150-00030","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000505434","article-title":"Evolution and revolution of hepatitis C management: from non-A, non-B hepatitis toward global elimination","author":"Basyte-Bacevice V","year":"2020","unstructured":"Basyte-Bacevice V, Kupcinskas J. Evolution and revolution of hepatitis C management: from non-A, non-B hepatitis toward global elimination. Dig Dis. 2020, 1-6. 10.1159\/000505434","journal-title":"Dig Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191791-a-case-of-epstein-barr-virus-negative-post-transplant-lymphoproliferative-disorder-in-a-solid-organ-transplant-recipient-with-untreated-chronic-hepatitis-c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:43Z","timestamp":1707509683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191791-a-case-of-epstein-barr-virus-negative-post-transplant-lymphoproliferative-disorder-in-a-solid-organ-transplant-recipient-with-untreated-chronic-hepatitis-c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.53323","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}